Mar 28 2024
News
Feb 15 2024
Astellas and Kelonia Therapeutics Enter into Research and License Agreement to Develop Novel Immuno-Oncology Therapeutics
May 17 2023
Kelonia Therapeutics Presents Research Highlighting Potential of iGPS® in vivo Gene Therapy to Bring Safe, Effective CAR T Therapies to Common Medical Practice for Treatment of All Multiple Myeloma Patients
May 2 2023
Kelonia Therapeutics Announces Upcoming Oral Presentation of Preclinical Data with First Details of iGPS™ Technology at ASGCT Annual Meeting
Apr 28 2022